» Authors » Steven C Cheng

Steven C Cheng

Explore the profile of Steven C Cheng including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 136
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheng S, Pivert K, Sozio S
Clin J Am Soc Nephrol . 2022 Jul; 17(11):1691-1693. PMID: 35853729
No abstract available.
2.
Seifert M, de las Fuentes L, Ginsberg C, Rothstein M, Dietzen D, Cheng S, et al.
Am J Nephrol . 2014 May; 39(5):392-9. PMID: 24818573
Background/aims: Progressive chronic kidney disease (CKD) is associated with worsening cardiovascular (CV) risk not explained by traditional risk factors. Left ventricular (LV) hypertrophy (LVH) is an important CV risk factor,...
3.
Seifert M, de las Fuentes L, Rothstein M, Dietzen D, Bierhals A, Cheng S, et al.
Am J Nephrol . 2013 Aug; 38(2):158-67. PMID: 23941761
Background/aims: Cardiovascular disease (CVD) is increased in chronic kidney disease (CKD), and contributed to by the CKD-mineral bone disorder (CKD-MBD). CKD-MBD begins in early CKD and its vascular manifestations begin...
4.
Young D, Cheng S, Delmez J, Coyne D
Perit Dial Int . 2009 Sep; 29(5):562-7. PMID: 19776051
Background: Hyperphosphatemia remains a significant problem for patients requiring dialysis and is associated with increased mortality. Current treatment options include dietary restriction, dialysis, and phosphate binders. Treatment using the latter...
5.
Cheng S, Young D, Huang Y, Delmez J, Coyne D
Clin J Am Soc Nephrol . 2008 Apr; 3(4):1131-8. PMID: 18385391
Background And Objectives: Niacinamide inhibits intestinal sodium/phosphorus transporters and reduces serum phosphorus in open-label studies. A prospective, randomized, double-blind, placebo-controlled crossover trial was performed for assessment of the safety and...